The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster.
作者信息
Krausz R Michael, Westenberg Jean N, Meyer Maximilian, Choi Fiona
机构信息
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; Center for Addictive Disorders, University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland.
出版信息
Lancet Psychiatry. 2022 Sep;9(9):699-700. doi: 10.1016/S2215-0366(22)00241-3.
Abstract
摘要
相似文献
1
The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster.即将到来的合成超强效阿片类药物浪潮是一场可预见的灾难。
Lancet Psychiatry. 2022 Sep;9(9):699-700. doi: 10.1016/S2215-0366(22)00241-3.
2
Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.桑迪飓风过后六个月，基于办公室的丁丙诺啡项目中的精神疾病共病与物质使用结果
Subst Use Misuse. 2015;50(12):1571-8. doi: 10.3109/10826084.2015.1023455. Epub 2015 Nov 19.
3
[Ethical Duties in Disaster Preparedness.].[灾害准备中的道德责任。]
Rev Esp Salud Publica. 2022 Oct 5;96:e202210071.
4
Abuse deterrence focus of upcoming opioid formulations.
Am J Health Syst Pharm. 2008 Mar 1;65(5):381, 385. doi: 10.2146/news080018.
5
The criminalization of treating end of life patients with risky pain medication and the role of the extreme emergency situation.
Fordham Law Rev. 2007 Oct;76(1):203-34.
6
Dr. Pou and the hurricane--implications for patient care during disasters.Pou医生与飓风——灾难期间对患者护理的启示。
N Engl J Med. 2008 Jan 3;358(1):1-5. doi: 10.1056/NEJMp0707917.
7
Selective attrition and bias in a longitudinal health survey among survivors of a disaster.一场灾难幸存者纵向健康调查中的选择性损耗与偏差。
BMC Med Res Methodol. 2007 Feb 15;7:8. doi: 10.1186/1471-2288-7-8.
8
Perspectives on cannabis as a substitute for opioid analgesics.关于大麻作为阿片类镇痛药替代品的观点。
Pain Manag. 2019 Mar 1;9(2):191-203. doi: 10.2217/pmt-2018-0051. Epub 2019 Jan 25.
9
President's message: Deliberate epidemics.
J Addict Dis. 2017 Oct-Dec;36(4):264-265. doi: 10.1080/10550887.2017.1390329.
10
AH-7921: a new synthetic opioid of abuse.
Drug Alcohol Rev. 2015 Jan;34(1):109-10. doi: 10.1111/dar.12216. Epub 2014 Oct 10.
引用本文的文献
1
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries.通过废水分析早期识别强效苄基苯并咪唑类药物（硝氮烯）的使用情况：来自22个国家的两年数据。
Addiction. 2025 Mar 18. doi: 10.1111/add.70027.
2
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh.苏格兰更安全药物消费设施的实施：爱丁堡市的混合方法需求评估与可行性研究
Harm Reduct J. 2025 Jan 13;22(1):6. doi: 10.1186/s12954-024-01144-1.
3
Challenges for the implementation of injectable opioid agonist treatment: a scoping review.注射用阿片类激动剂治疗实施面临的挑战：一项范围综述
Harm Reduct J. 2024 Dec 4;21(1):217. doi: 10.1186/s12954-024-01102-x.
4
Hazardous Materials from Threats to Safety: Molecularly Imprinted Polymers as Versatile Safeguarding Platforms.威胁安全的有害物质：分子印迹聚合物作为多功能防护平台
Polymers (Basel). 2024 Sep 24;16(19):2699. doi: 10.3390/polym16192699.
5
[Challenges in the treatment of opioid dependence].[阿片类药物依赖治疗中的挑战]
Nervenarzt. 2024 Sep;95(9):811-817. doi: 10.1007/s00115-024-01691-9. Epub 2024 Jul 15.
6
Preference for hotline versus mobile application/countdown-based mobile overdose response services: a qualitative study.对热线与移动应用程序/基于倒计时的过量用药应对服务的偏好：一项定性研究。
Harm Reduct J. 2024 Feb 5;21(1):31. doi: 10.1186/s12954-024-00944-9.
7
Shifting drug markets in North America - a global crisis in the making?北美不断变化的毒品市场——一场正在形成的全球危机？
Int J Ment Health Syst. 2023 Oct 25;17(1):36. doi: 10.1186/s13033-023-00601-x.
8
A Call for an Evidence-Based Strategy Against the Overdose Crisis.呼吁制定基于证据的应对药物过量危机的策略。
Can J Psychiatry. 2024 Jan;69(1):5-9. doi: 10.1177/07067437231188202. Epub 2023 Jul 12.
9
Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs.检测、化学分析和药理学特性研究——二苯甲酮和其他与处方药物相关的新型合成阿片类药物。
Anal Bioanal Chem. 2023 Sep;415(21):5165-5180. doi: 10.1007/s00216-023-04722-7. Epub 2023 May 13.
10
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.经鼻给予海洛因辅助治疗的安全性和可行性：来自瑞士多中心观察性研究的 4 周初步结果。
Harm Reduct J. 2023 Jan 7;20(1):2. doi: 10.1186/s12954-023-00731-y.
本文引用的文献
1
Modeling the evolution of the US opioid crisis for national policy development.为国家政策制定模拟美国阿片类药物危机的演变。
Proc Natl Acad Sci U S A. 2022 Jun 7;119(23):e2115714119. doi: 10.1073/pnas.2115714119. Epub 2022 May 31.
2
Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.新型2-苄基苯并咪唑类“硝甲西泮”合成阿片类药物N-吡咯烷基依托尼嗪（依托尼泽平）的药理学评价及法医案例系列
Arch Toxicol. 2022 Jun;96(6):1845-1863. doi: 10.1007/s00204-022-03276-4. Epub 2022 Apr 28.
3
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.应对北美及其他地区的阿片类药物危机：斯坦福-柳叶刀委员会的建议
Lancet. 2022 Feb 5;399(10324):555-604. doi: 10.1016/S0140-6736(21)02252-2. Epub 2022 Feb 2.
4
Shifting North American drug markets and challenges for the system of care.北美药品市场的变化及医疗体系面临的挑战。
Int J Ment Health Syst. 2021 Dec 20;15(1):86. doi: 10.1186/s13033-021-00512-9.
Zotero 插件